Antibiotic prophylaxis showed no clear difference in symptomatic UTI by 1 to 2 years: antibiotics versus no prophylaxis compared with surveillance or no treatment (low certainty).
Antibiotic prophylaxis showed no clear difference in febrile UTI by 1 to 2 years: antibiotics versus no prophylaxis compared with surveillance or no treatment (low certainty).
Antibiotic prophylaxis showed no clear difference in resolution of VUR after 1 to 2 years: unit of analysis (children) compared with surveillance or no treatment (low certainty).
Antibiotic prophylaxis showed no clear difference in adverse events compared with surveillance or no treatment (moderate certainty).
Antibiotic prophylaxis probably leads to higher microbial resistance to prophylactic drug: unit of analysis (UTI) compared with surveillance or no treatment (moderate certainty).
Probiotics showed no clear difference in all symptomatic UTI by 1 year compared with antibiotic prophylaxis (low certainty).
Probiotics showed no clear difference in febrile UTI by 1 year compared with antibiotic prophylaxis (low certainty).
Probiotics may leads to lower E. coli resistance to prophylactic drug compared with antibiotic prophylaxis (low certainty).
Probiotics showed no clear difference in renal parenchymal defects on DMSA scan ‐ Patient data at 1 year compared with antibiotic prophylaxis (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Isoniazid probably leads to lower tuberculosis compared with no treatment (moderate certainty).
Isoniazid probably leads to higher INH hepatotoxicity Jaundice, elevated bilirubin, elevated liver… compared with no treatment (moderate certainty).
Isoniazid showed no clear difference in all‐cause mortality compared with no treatment (low certainty).